EyeMirage Device for Visual Function

Recruiting at 5 trial locations

Overseen By Bram Ramjiawan, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Neuroptek Corporation Inc.

Disqualifiers: Blindness, Alzheimer's, Parkinson's, Stroke, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 2

Duration: 1 day

160 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new device, EyeMirage, to compare its effectiveness with standard eye tests. It measures visual acuity (clarity of vision), visual field (the area visible), color vision, and eye movements. The trial includes individuals with vision of 20/200 or better who are willing to try both the new and standard tests. Those with severe vision loss or certain neurological conditions are not eligible. As an unphased trial, participants contribute to innovative research that may enhance future eye care.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that the EyeMirage device is safe for eye function testing?

Research has shown that the EyeMirage device assesses various aspects of eye function, such as visual acuity, visual field, color vision, and self-paced saccades. The device has been compared to standard tests conducted in eye clinics.

No reports of problems or safety issues have emerged from these comparisons. This trial focuses on evaluating the effectiveness of the EyeMirage device, not on testing a new drug or surgical treatment, which typically involves fewer safety concerns. Participants will have a follow-up to discuss any issues, but current evidence suggests the device is safe to use. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Researchers are excited about the EyeMirage device because it offers a new way to assess vision by integrating technology with traditional methods. Unlike standard tests that are often separate and manual, EyeMirage combines visual acuity, visual field, color vision, and saccade assessments into one streamlined digital process using both a device and an app. This method promises to be faster and potentially more convenient for both patients and healthcare providers, while also delivering comprehensive results. By comparing EyeMirage directly with standard care, researchers aim to find out if this innovative approach can enhance the accuracy and efficiency of visual function assessments.

What evidence suggests that the EyeMirage device is effective for eye function testing?

Research has shown that the EyeMirage device holds promise for testing eye functions such as visual clarity, peripheral vision, color vision, and eye movement speed. In this trial, one group of participants will first undergo assessments using standard tests, followed by the EyeMirage device, while another group will use the EyeMirage device first, followed by standard tests. Early studies found that EyeMirage produces results similar to standard eye clinic tests. This suggests the device might be as reliable as traditional methods. EyeMirage could offer accurate and effective eye health assessments, making it a potential tool for eye exams. ^{2 3 5 6 7}

Who Is on the Research Team?

Bram Ramjiawan, PhD

Principal Investigator

St. Boniface Hospital Asper Clinical Research Institute

Are You a Good Fit for This Trial?

This clinical trial is for individuals aged 18 to 65 who are undergoing standard eye examinations. Participants will be assessed using both the EyeMirage device and standard devices during a single clinic visit, with a follow-up call after thirty days.

Inclusion Criteria

Evidence of a signed and dated informed consent document confirming that the participant has been informed of all aspects of the clinical study

Visual acuity of 20/200 or better

Willingness to comply with required screening procedures, eye assessments, and follow-up visits, if needed

Exclusion Criteria

Visual acuity worse than 20/200 in either eye

Eyes with a spherical equivalent of greater than +9 or -9 diopters where the corrective lens is too large to fit in the headset

I am completely blind or have severe vision loss in one eye.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo four eye tests using both the new EyeMirage device and the standard of care devices

1 day

1 visit (in-person)

Follow-up

Participants are monitored for any issues and discuss results 30 days after the eye tests

4 weeks

1 call (virtual)

What Are the Treatments Tested in This Trial?

Interventions

• EyeMirage

Trial Overview

The trial is testing the EyeMirage device's effectiveness by comparing it against standard eye examination tools. It measures visual acuity, visual field, color vision, and saccade timing in patients with various conditions.

How Is the Trial Designed?

Group I: Standard of Care Experimental Treatment 1 Intervention

This Cohort will undergo assessments for visual acuity, visual field, color vision, and self-paced saccade first via the current standard of care tests and then using the EyeMirage device and app.

Group II: EyeMirage Experimental Treatment 1 Intervention

This Cohort will undergo assessments for visual acuity, visual field, color vision, and self-paced saccade first via the EyeMirage device and app, then via the standard of care tests.

Who Is Running the Clinical Trial?

Neuroptek Corporation Inc.

Lead Sponsor

St. Boniface Hospital

Collaborator

Trials

55

Recruited

15,000+

St. Boniface Hospital Asper Clinical Research Institute

Collaborator

Citations

1.

clinicaltrials.gov

clinicaltrials.gov/study/NCT06908967

A Performance Study Comparing the EyeMirage (Test ...

Results of the eye assessments for visual acuity, visual field, color vision, and self-paced saccade using the EyeMirage device and app, and standard of ...

2.

withpower.com

withpower.com/trial/phase-visual-function-3-2025-71c9c

EyeMirage Device for Visual Function

This study will assess the effectiveness and accuracy of results of a new device for eye function testing. This will be done by comparing results of four ...

3.

app.trialscreen.org

app.trialscreen.org/trials/performance-comparing-eyemirage-test-device-to-standard-care-reference-trial-nct06908967

A Performance Study Comparing the EyeMirage (Test ...

The study aims to assess the effectiveness and accuracy of a new device called EyeMirage in performing standard eye examinations like visual acuity, visual ...

4.

clinconnect.io

clinconnect.io/trials/NCT06908967

A Performance Study Comparing the EyeMirage (Test

This study will assess the effectiveness and accuracy of results of a new device for eye function testing. This will be done by comparing results of four ...

5.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC7527608/

Assessing Saccadic Eye Movements With Head-Mounted ...

The purpose of this study is to evaluate whether the device can be used as an assessment tool of saccadic eye movement and to investigate the technical ...

6.

neuroptek.com

neuroptek.com/

Neuroptek - Virtual eye testing simplified

Visual Acuity test is used to determine the smallest letters you can read on a standardized chart. With EyeMirage™ you can test your vision the same way you get ...

7.

journals.lww.com

journals.lww.com/optvissci/fulltext/2023/12000/eye_tracking_to_assess_the_functional_consequences.8.aspx

Eye Tracking to Assess the Functional Consequences of...

This study aimed to establish the degree to which video-based eye tracking can be used to assess visual function in the presence of vision impairment.